Liposomes and nanotechnology in drug development: focus on oncotargets

References

• MuthuMSSinghSTargeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disordersNanomedicine (Lond)20094110511819093899
   PubMed Web of Science ®Google Scholar
• AlbertMLSauterBBhardwajNDendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLsNature1998392667186899510252
   PubMed Web of Science ®Google Scholar
• KawakamiYFujitaTKudoCDendritic cell based personalized immunotherapy based on cancer antigen researchFront Biosci2008131952195817981682
   PubMed Web of Science ®Google Scholar
• KozakoTNew strategy of adult T-cell leukemia treatment targeted for anti-tumor immunity and a longevity gene-encoded proteinYakugaku Zasshi201113171061107221720136
   PubMed Web of Science ®Google Scholar
• YasunagaJSakaiTNosakaKImpaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient stateBlood200197103177318311342446
   PubMed Web of Science ®Google Scholar
• HarashimaNKuriharaKUtsunomiyaAGraft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantationCancer Res200464139139914729650
   PubMed Web of Science ®Google Scholar
• IkeharaYShiuchiNKabata-IkeharaSEffective induction of anti-tumor immune responses with oligomannose-coated liposome targeting to intraperitoneal phagocytic cellsCancer Lett20082601–213714518077084
   PubMed Web of Science ®Google Scholar
• MatsuiMShimizuYKoderaYKondoEIkeharaYNakanishiHTargeted delivery of oligomannose-coated liposome to the omental micrometastasis by peritoneal macrophages from patients with gastric cancerCancer Sci201010171670167720507320
   PubMed Web of Science ®Google Scholar
• TakagiHFuruyaNKojimaNPreferential production of IL-12 by peritoneal macrophages activated by liposomes prepared from neoglycolipids containing oligomannose residuesCytokine200740324125018060800
   PubMed Web of Science ®Google Scholar
• KozakoTHirataSShimizuYOligomannose-coated liposomes efficiently induce human T-cell leukemia virus-1-specific cytotoxic T lymphocytes without adjuvantFEBS J201127881358136621332943
   PubMed Web of Science ®Google Scholar
• GrgacicEVAndersonDAVirus-like particles: passport to immune recognitionMethods2006401606516997714
   PubMed Web of Science ®Google Scholar
• ZhangSCubasRLiMChenCYaoQVirus-like particle vaccine activates conventional B2 cells and promotes B cell differentiation to IgG2a producing plasma cellsMol Immunol200946101988200119376580
   PubMed Web of Science ®Google Scholar
• CuiZHuangLLiposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: therapeutic effect against cervical cancerCancer Immunol Immunother200554121180119015846491
   PubMed Web of Science ®Google Scholar
• WhitmoreMMLiSFaloLJrHuangLSystemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responsesCancer Immunol Immunother2001501050351411776372
   PubMed Web of Science ®Google Scholar
• MalyalaPO’HaganDTSinghMEnhancing the therapeutic efficacy of CpG oligonucleotides using biodegradable microparticlesAdv Drug Deliv Rev200961321822519168103
   PubMed Web of Science ®Google Scholar
• BadieeAJaafariMRSamieiASoroushDKhamesipourACoencapsulation of CpG oligodeoxynucleotides with recombinant Leishmania major stress-inducible protein 1 in liposome enhances immune response and protection against leishmaniasis in immunized BALB/c miceClin Vaccine Immunol200815466867418235040
   PubMed Web of Science ®Google Scholar
• LiSHuangLIn vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexesGene Ther1997498919009349425
   PubMed Web of Science ®Google Scholar
• YanWChenWHuangLMechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokinesMol Immunol200744153672368117521728
   PubMed Web of Science ®Google Scholar
• ChenWYanWHuangLA simple but effective cancer vaccine consisting of an antigen and a cationic lipidCancer Immunol Immunother200857451753017724588
   PubMed Web of Science ®Google Scholar
• BhowmickSMazumdarTSinhaRAliNComparison of liposome based antigen delivery systems for protection against Leishmania donovaniJ Control Release2010141219920719818373
   PubMed Web of Science ®Google Scholar
• IkeharaYNiwaTBiaoLA carbohydrate recognition-based drug delivery and controlled release system using intraperitoneal macrophages as a cellular vehicleCancer Res200666178740874816951190
   PubMed Web of Science ®Google Scholar
• KawamuraKKadowakiNSuzukiRDendritic cells that endocytosed antigen-containing IgG-liposomes elicit effective antitumor immunityJ Immunother200629216517416531817
   PubMed Web of Science ®Google Scholar
• HiraiMMinematsuHKondoNOieKIgarashiKYamazakiNAccumulation of liposome with Sialyl Lewis X to inflammation and tumor region: application to in vivo bio-imagingBiochem Biophys Res Commun2007353355355817189617
   PubMed Web of Science ®Google Scholar
• McGrealEPMartinez-PomaresLGordonSDivergent roles for C-type lectins expressed by cells of the innate immune systemMol Immunol200441111109112115476922
   PubMed Web of Science ®Google Scholar
• RobinsonMJSanchoDSlackECLeibundGut-LandmannSReis e SousaCMyeloid C-type lectins in innate immunityNat Immunol20067121258126517110942
   PubMed Web of Science ®Google Scholar
• AdamsEWRatnerDMSeebergerPHHacohenNCarbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cellsChembiochem20089229430318186095
   PubMed Web of Science ®Google Scholar
• TurnerMWMannose-binding lectin: the pluripotent molecule of the innate immune systemImmunol Today199617115325408961631
   PubMedGoogle Scholar
• GeijtenbeekTBTorensmaRvan VlietSJIdentification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responsesCell2000100557558510721994
   PubMed Web of Science ®Google Scholar
• StambachNSTaylorMECharacterization of carbohydrate recognition by langerin, a C-type lectin of Langerhans cellsGlycobiology200313540141012626394
   PubMed Web of Science ®Google Scholar
• SinghSKStephaniJSchaeferMTargeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentationMol Immunol2009472–316417419818504
   PubMed Web of Science ®Google Scholar
• IshiiMKoyamaAIsekiHNarumiHYokoyamaNKojimaNAnti-allergic potential of oligomannose-coated liposome-entrapped Cry j 1 as immunotherapy for Japanese cedar pollinosis in miceInt Immunopharmacol20101091041104620584630
   PubMed Web of Science ®Google Scholar
• KojimaNBiaoLNakayamaTIshiiMIkeharaYTsujimuraKOligomannose-coated liposomes as a therapeutic antigen-delivery and an adjuvant vehicle for induction of in vivo tumor immunityJ Control Release20081291263218485512
   PubMed Web of Science ®Google Scholar
• NishikawaYZhangHIkeharaYKojimaNXuanXYokoyamaNImmunization with oligomannose-coated liposome-entrapped dense granule protein 7 protects dams and offspring from Neospora caninum infection in miceClin Vaccine Immunol200916679279719357313
   PubMedGoogle Scholar
• ShimizuYTakagiHNakayamaTIntraperitoneal immunization with oligomannose-coated liposome-entrapped soluble leishmanial antigen induces antigen-specific T-helper type immune response in BALB/c mice through uptake by peritoneal macrophagesParasite Immunol200729522923917430546
   PubMed Web of Science ®Google Scholar
• JanewayCAJrMedzhitovRInnate immune recognitionAnnu Rev Immunol20022019721611861602
   PubMed Web of Science ®Google Scholar
• KawaiTAkiraSPathogen recognition with Toll-like receptorsCurr Opin Immunol200517433834415950447
   PubMed Web of Science ®Google Scholar
• KatoCKajiwaraTNumazakiMTakagiHKojimaNOligomannose-coated liposomes activate ERK via Src kinases and PI3K/Akt in J774 A.1 cellsBiochem Biophys Res Commun2008372489890118538131
   PubMed Web of Science ®Google Scholar
• KojimaNKawauchiYIshiiMDevelopment of novel carbohydrate-coated liposome-based vaccinesTrends Glycosci Glycotechnol201123134257271
   Web of Science ®Google Scholar
• MizuuchiMHirohashiYTorigoeTNovel oligomannose liposome-DNA complex DNA vaccination efficiently evokes anti-HPV E6 and E7 CTL responsesExp Mol Pathol201292118519022032938
   PubMed Web of Science ®Google Scholar
• IshiiMKojimaNMucosal adjuvant activity of oligomannose-coated liposomes for nasal immunizationGlycoconj J201027111512319816665
   PubMed Web of Science ®Google Scholar
• HinumaYNagataKHanaokaMAdult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human seraProc Natl Acad Sci U S A19817810647664807031654
   PubMed Web of Science ®Google Scholar
• PoieszBJRuscettiFWGazdarAFBunnPAMinnaJDGalloRCDetection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphomaProc Natl Acad Sci U S A19807712741574196261256
   PubMed Web of Science ®Google Scholar
• TsukasakiKHermineOBazarbachiADefinition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meetingJ Clin Oncol200927345345919064971
   PubMed Web of Science ®Google Scholar
• TaylorGPMatsuokaMNatural history of adult T-cell leukemia/lymphoma and approaches to therapyOncogene200524396047605716155611
   PubMed Web of Science ®Google Scholar
• TsukasakiKUtsunomiyaAFukudaHVCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801J Clin Oncol200725345458546417968021
   PubMed Web of Science ®Google Scholar
• YamadaYTomonagaMFukudaHA new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303Br J Haematol2001113237538211380402
   PubMed Web of Science ®Google Scholar
• YoshidaMMolecular approach to human leukemia: isolation and characterization of the first human retrovirus HTLV-1 and its impact on tumorigenesis in adult T-cell leukemiaProc Jpn Acad Ser B Phys Biol Sci2010862117130
   Web of Science ®Google Scholar
• YasunagaJMatsuokaMLeukaemogenic mechanism of human T-cell leukaemia virus type IRev Med Virol200717530131117621367
   PubMed Web of Science ®Google Scholar
• JacobsonSShidaHMcFarlinDEFauciASKoenigSCirculating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological diseaseNature199034862982452482146511
   PubMed Web of Science ®Google Scholar
• BanghamCRHTLV-1 infection: role of CTL efficiencyBlood200811262176217718779398
   PubMed Web of Science ®Google Scholar
• KozakoTAkimotoMTojiSTarget epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disordersJ Med Virol201183350150921264872
   PubMed Web of Science ®Google Scholar
• KozakoTArimaNTojiSReduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD8+ T cell in adult T cell leukemia patientsJ Immunol200617785718572617015761
   PubMed Web of Science ®Google Scholar
• KozakoTYoshimitsuMAkimotoMProgrammed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disordersHum Immunol201172111001100621851845
   PubMed Web of Science ®Google Scholar
• KozakoTYoshimitsuMFujiwaraHPD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patientsLeukemia200923237538218830259
   PubMed Web of Science ®Google Scholar
• OhashiTHanabuchiSKatoHPrevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccineJ Virol200074209610961611000233
   PubMed Web of Science ®Google Scholar
• FukasawaMShimizuYShikataKLiposome oligomannose-coated with neoglycolipid, a new candidate for a safe adjuvant for induction of CD8+ cytotoxic T lymphocytesFEBS Lett199844133533569891969
   PubMed Web of Science ®Google Scholar
• SugimotoMOhishiKFukasawaMOligomannose-coated liposomes as an adjuvant for the induction of cell-mediated immunityFEBS Lett19953631–253567729553
   PubMed Web of Science ®Google Scholar
• MilichDRMcLachlanAThorntonGBHughesJLAntibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell siteNature198732961395475492443856
   PubMed Web of Science ®Google Scholar
• StorniTLechnerFErdmannICritical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particlesJ Immunol200216862880288611884458
   PubMed Web of Science ®Google Scholar
• KozakoTFukadaKHirataSEfficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemiaMol Immunol2009472–360661319889459
   PubMed Web of Science ®Google Scholar